Noor noted patients benefit from in-house injection services, avoiding the inconvenience of traveling to off-site centers.
Buy-and-Bill
Latest News
Advertisement
CME Content
Advertisement
Noor emphasizes that patient access is the primary consideration when deciding to use the buy-and-bill model.
Dermatology Times' Spring Editor in Chief, Aaron Farberg, MD, discusses the business strategy known as buy and bill.
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Accepts Addition of Bemotrizinol as First New Sunscreen Ingredient in 20 Years
2
Digital Twins in Dermatology: Your Patient’s Virtual Double Is Coming
3
Once-Daily Zasocitinib Rivals Injectable Biologics for Skin Clearance, Phase 3 Data Show
4
Moving Past Dermal Filler Trends to Focus on Healthy Skin Aging
5